Amicus Therapeutics (FOLD) Misses Q1 EPS by 14c
Tweet
Share
E-mailGet Alerts FOLD Hot Sheet
Price: $14.49 --0%
Financial Fact:
Research and development: 32.46M
Today's EPS Names:
JAGX, CLIR, ZTO, More
Financial Fact:
Research and development: 32.46M
Today's EPS Names:
JAGX, CLIR, ZTO, More
Join SI Premium – FREE
Amicus Therapeutics (NASDAQ: FOLD) reported Q1 EPS of ($0.35), $0.14 worse than the analyst estimate of ($0.21).
For earnings history and earnings-related data on Amicus Therapeutics (FOLD) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Nordson Corp. (NDSN) Tops Q3 EPS by 16c; Offers Guidance
- Lowe's slashes full-year sales outlook amid DIY spending pressure
- Bill.com (BILL) Tops Q4 EPS by 14c, Beats on Revenue; Offers FY27 Guidance
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
